{
  "paper_metadata": {
    "pmid": "16168123",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the BRCA2 variant S384F, providing details on its clinical significance, penetrance data, and individual case information."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1151A>T",
      "protein_notation": "p.Ser384Phe",
      "genomic_position": null,
      "clinical_significance": "VUS (variant of unknown significance)",
      "patients": {
        "count": 4,
        "demographics": "Four women, ages 32, 41, 43, and 57",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 116,
        "affected_count": 3,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 2.586206896551724,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "326.1",
          "age_at_evaluation": 43,
          "age_at_onset": null,
          "age_at_diagnosis": 43,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Unilateral breast cancer",
          "evidence_sentence": "The variant S384F was first identified in patient 326.1, who suffered from uni-lateral breast cancer at 43 years of age."
        },
        {
          "individual_id": "326.2",
          "age_at_evaluation": 41,
          "age_at_onset": null,
          "age_at_diagnosis": 41,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Unilateral breast cancer",
          "evidence_sentence": "Further analysis showed that patients 326.2 and 326.4 (uni-lateral breast cancers at 41 and 57 years of age, respectively) were also carriers of the S384F variant."
        },
        {
          "individual_id": "326.3",
          "age_at_evaluation": 50,
          "age_at_onset": 32,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Bilateral breast cancer",
          "evidence_sentence": "In contrast, a patient with bilateral breast cancer (ID326.3, diagnosed at 32 and 50 years of age) did not exhibit the variant."
        },
        {
          "individual_id": "326.4",
          "age_at_evaluation": 57,
          "age_at_onset": null,
          "age_at_diagnosis": 57,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Unilateral breast cancer",
          "evidence_sentence": "Further analysis showed that patients 326.2 and 326.4 (uni-lateral breast cancers at 41 and 57 years of age, respectively) were also carriers of the S384F variant."
        }
      ],
      "functional_data": {
        "summary": "The S384F variant results in a non-conservative substitution of a hydrophilic amino acid (Ser) by a hydrophobic one (Phe).",
        "assays": []
      },
      "segregation_data": "The variant was detected in three of the four breast cancer patients.",
      "population_frequency": "Not detected in 200 healthy control women over the age of 60 years.",
      "evidence_level": "Combined likelihood ratio of 1.4 \u00d7 10-8 in favour of neutrality.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is not located in a region of functional importance.",
      "key_quotes": [
        "Our data provide conclusive evidence that the S384F variant is not a disease causing mutation.",
        "The combined likelihood ratio of co-occurrence, co-segregation and loss of heterozygosity revealed a value of 1.4 \u00d7 10-8 in favour of neutrality of the variant."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}